About us

Avetra Bioscience develops and markets cancer pathway specific reagents for life science research and development community.  Our innovative product development platform allows us to develop and validate our products with high success rate.  Our current products include:

  • Onco-Path siRNA libraries
  • Onco-Path antibodies

Besides catalog products, Avetra offers custom specialty oligonucleotide synthesis service, preclinical in vitro and in vivo pharmacology studies and assay development service.  Our top tier chemists and biologists stand ready to work with you on your projects.

Avetra also focuses on collaborations.  By working with industry’s thought leaders, innovators and other bright scientists, Avetra strives to be one of the most innovative life science reagents company.  Our goal is to help researchers obtain high quality data faster and easier.  Contact us at info@avetrabio.com to see if we can work together.  We are always interested in expanding our knowledge base and developing innovative products.